ARCHIVES

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

In Congress: Clinton Backs Genetic Privacy Bills, But Plans Changes Proposals

July 18, 1997

Radiotherapy Plus Cetuximab May Control Head/Neck Cancer

November 26, 2010

Roswell Park Instigators Find Improved Treatment For Bladder Cancer

May 23, 1975

In Brief: Moertel To Deliver Karnofsky Lecture; Hopkins, Cold Spring Harbor Receive Bristol-Myers Awards

April 25, 1986

In Brief: Fischinger, SAIC Win $400 Million Contract

March 3, 1995

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000